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Nucleotide sugar transporters (NSTs) regulate the flux of acti-
vated sugars from the cytosol into the lumen of the Golgi appa-
ratus where glycosyltransferases use them for the modification
of proteins, lipids, and proteoglycans. It has been well-estab-
lished that NSTs are antiporters that exchange nucleotide
sugars with the respective nucleoside monophosphate. Never-
theless, information about the molecular basis of ligand recog-
nition and transport is scarce. Here, using topology predictors,
cysteine-scanning mutagenesis, expression of GFP-tagged pro-
tein variants, and phenotypic complementation of the yeast
strain Kl3, we identified residues involved in the activity of a
mouse UDP-GlcNAc transporter, murine solute carrier family
35 member A3 (mSlc35a3). We specifically focused on the puta-
tive transmembrane helix 2 (TMH2) and observed that cells
expressing E47C or K50C mSlc35a3 variants had lower levels of
GlcNAc-containing glycoconjugates than WT cells, indicating
impaired UDP-GlcNAc transport activity of these two variants.
A conservative substitution analysis revealed that single or dou-
ble substitutions of Glu-47 and Lys-50 do not restore GlcNAc
glycoconjugates. Analysis of mSlc35a3 and its genetic variants
reconstituted into proteoliposomes disclosed the following:
(i) all variants act as UDP-GlcNAc/UMP antiporters; (ii) con-
servative substitutions (E47D, E47Q, K50R, or K50H) impair
UDP-GlcNAc uptake; and (iii) substitutions of Glu-47 and
Lys-50 dramatically alter kinetic parameters, consistent with a
critical role of these two residues in mSlc35a3 function. A bioin-
formatics analysis revealed that an EXXK motif in TMH2 is
highly conserved across SLC35 A subfamily members, and a
3D-homology model predicted that Glu-47 and Lys-50 are fac-
ing the central cavity of the protein.
Nucleotide sugars play a key role as precursors for the bio-
synthesis of glycoconjugates in the secretory pathway. These
activated sugar donors serve as substrates for glycosyltrans-
ferases. Although they are on the cytoplasmic side of the endo-
plasmic reticulum (ER),7 they allow the attachment of sugars to
dolichol phosphate to form glycosylated lipid precursors, and
within the Golgi lumen, they are required for the glycosylation
of proteins, lipids, and proteoglycans. To enable the latter and
to overcome the subcellular partitioning of substrates and
enzymes, nucleotide sugars are required to be imported from
the cytoplasm into the Golgi lumen by specific membrane pro-
teins, the so-called nucleotide sugar transporters (NSTs) (1, 2).
The physiological relevance of this transport process is well-
documented from unicellular (3) to multicellular organisms (4,
5), whereas mutations that impair NST function are associated
with severe developmental phenotypes.
Based on biochemical (6) and genetic approaches (7), an anti-
port mechanism exchanging a nucleotide sugar with the corre-
sponding nucleoside monophosphate has been proposed for
NST function (2). The cloning, expression, and functional char-
acterization of more than 60 NSTs from diverse species
revealed that some of them act as monospecific transporters,
whereas others turned out to have the capability of transporting
multiple substrates in a competitive or simultaneous process
(8 –17).
Based on sequence analyses, mammalian NSTs were clas-
sified as members of the solute carrier 35 family (SLC35),
together with 3-phosphoadenosine–5-phosphosulfate (18)
and ATP transporters (19). However, of the 24 members of the
SLC35 subfamilies A–G, only half have been experimentally
characterized in different species, including humans (18). In
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humans, mutations of five NSTs of the SLC35 family with
diverse substrate specificities, namely A1 (20, 21), A2 (22, 23),
A3 (24), C1 (25–27), and D1 (28), are linked to congenital dis-
orders of glycosylation that cause diverse severe neurological
and skeletal anomalies.
Among the Slc35 family, subfamily A is the most thor-
oughly characterized. For three of its five members substrate
specificities have been identified. A1, A2, and A3 are specific for
CMP-sialic acid (CMP-SA) (29), UDP-galactose (UDP-Gal)
(30), and UDP-GlcNAc (31), respectively. Studies determining
the topology of the mouse CMP-SA transporter Slc35a1, using
a epitope-insertion technique, indicated a 10-transmembrane
protein with the N and C termini facing the cytosol (32). Fur-
thermore, studies using chimeric mutants of A1 and A2 (33,
34), as well as mutational analyses (35, 36), identified trans-
membrane domains and residues critically important for the
recognition of CMP-SA as a substrate.
Another well-characterized member of the subfamily A,
Slc35a3, is a Golgi-resident UDP-GlcNAc transporter present
in multicellular organisms with high-sequence conservation
from worms (4) to mammals (31). A mutation (V180F) in the
predicted transmembrane helix 6 of Slc35a3 causes complex
vertebral malformation in cattle (37), a lethal autosomal-reces-
sive defect. Recently, mutations of the human SLC35A3
ortholog have been associated with autism spectrum disorder,
epilepsy, and skeletal malformations. Affected patients carry
variants containing single amino acid changes or truncated
proteins (24, 38 – 40). Gene silencing of SLC35A3 in mamma-
lian cell lines affects the biosynthesis of highly branched N-
glycans and keratan sulfate (41) Furthermore, it has been
reported that the UDP-Gal (Slc35a2) and UDP-GlcNAc
(Slc35a3) transporters can associate with acetylglucosami-
nyltransferases (42) to form complexes, an observation that
may be related to the sequential addition of the sugars
GlcNAc, galactose, and sialic acid during the processing of
glycoproteins.
Since the first observation of nucleotide sugar uptake into
mouse liver microsomes (43), substantial efforts have been
made to understand NST function and physiological relevance
(1). However, information about the relationship between
structure and function is still scarce, and mechanisms under-
pinning nucleotide sugar transport at the molecular level
remain largely unknown. Recently, the first crystal structure of
NST was determined. The obtained 3D model of the yeast Vrg4
GDP-mannose transporter provided crucial information to
start understanding the molecular mechanisms of nucleotide
sugar import into the Golgi (44).
Here, we report a simple approach to test the in vivo function
of NSTs. This approach combined bioinformatic analyses, cys-
teine-scanning mutagenesis, GFP-based detection of protein
expression, and phenotypic complementation of yeast mutants
that allowed us to identify amino acids residues required for
UDP-GlcNAc transport activity of the mouse Slc35a3. A
detailed investigation of the transmembrane helix 2 from
Slc35a3 identified two critical residues, glutamic acid 47 and
lysine 50. Conservative replacements combined with in vivo
and in vitro activity assays confirmed the significance of both
residues for transport activity.
Results
Expression and transport activity of the mouse SLC35A3
assessed in yeast using a whole-cell fluorescence approach
Mouse Slc35a3 (mSLC35A3), a protein consisting of 326 amino
acids, shares between 95 and 96% sequence identity with four
mammalian SLC35A3 variants, which previously have been exper-
imentally characterized as Golgi-localized UDP-GlcNAc trans-
porters (31, 37, 45, 46). To confirm the substrate specificity of
mSlc35a3, Kl3 cells, a mutant strain of the yeast Kluveromyces lac-
tis lacking a functional UDP-GlcNAc transporter, were
transformed with either the empty vector (plasmid pE4) or
pE4mSLC35A3. Subsequently, the cells were incubated with GSII
lectin conjugated to FITC (GSII–FITC), which specifically binds
GlcNAc-containing glycoconjugates. Only the suspension of Kl3
cells transformed with pE4mSLC35A3 showed fluorescence
levels similar to that of WT Kl8 cells, carrying the functional
UDP-GlcNAc transporter, indicating that they recovered the abil-
ity to bind the lectin GSII–FITC (Fig. 1A, dark gray bars). In this
in vivo system, UDP-GlcNAc transport activity, mediated by
mSLC35A3, is indirectly evaluated through the restoration of
GlcNAc-containing glycoconjugates at the surface of Kl3 cells.
This implicates at least three steps as follows: the restoration of the
import of UDP-GlcNAc into the lumen of the Golgi apparatus
through expression of an active transporter; the synthesis of
GlcNAc glycoconjugates by specific lumenal transferases; and an
appropriate membrane cell-sorting process of these products (47).
One aim of this work was to generate a collection of mutants
and conveniently test their expression while avoiding time-
consuming methods. To achieve this, the sequence of the green
fluorescent protein (GFP) was fused to mSlc35a3. As shown in
Fig. 1C, perinuclear fluorescence in Kl3 cells transformed with
mSLC35A3–GFPcanbevisualizedbyconfocalmicroscopy,con-
sistent with the expression of mSlc35a3–GFP in the secretory
pathway. Subsequent spectrofluorimetric measurements of the
cell suspensions showed an increase in GFP fluorescence com-
pared with cells transformed with the empty vector (pE4) or
pE4mslc35a3 (Fig. 1A, white bars). Heating the cell suspensions
for 1 min at 90 °C reduced the fluorescence signal of mSlc35a3–
GFP-expressing cells to background levels of the control cells
transformed with the empty vector. This is most likely due to
the irreversible denaturation of the GFP fusion protein (Fig. 1,
A, gray bars, and C).
The results presented in Fig. 1A indicate that fusing GFP to
mSlc35a3 did not significantly alter its transport capacity (Fig.
1B) as revealed by the binding of the lectin. Next, the V180F
mutation that had been shown to impair transport activity of
the bovine Slc35a3 transporter (37) was introduced into the
mouse SLC35A3 sequence, and subsequently the Slc35a3
mutant was expressed as GFP fusion in K13 cells. Although the
expression level of the mutated variant was higher than the WT
protein (Fig. 1A, white bars), cells expressing the V180F variant
bound less than 25% of the GSII–FITC lectin compared with
cells expressing mSlc35a3–GFP (Fig. 1B). This indicates a sub-
stantial decrease in UDP-GlcNAc transport activity. Taken
together, our results suggest that this approach, based on het-
erologous expression of GFP-tagged proteins combined with
GSII–FITC lectin recognition of GlcNAc glycoconjugates, can
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successfully be employed to evaluate the expression and activity
of mSLC35A3.
Topology analysis of mSlc35a3
To identify amino acid residues relevant for transport
activity, we first analyzed the primary amino acid sequence
of mSlc35a3, using the topology predictors TOPCONS,
MEMSAT-SVM, HMMTOP, and TMHMM. As summarized
in Table S1, 8 –10 transmembrane helices (TMHs) were pre-
dicted for mSLC35A3. The data obtained from the different
prediction programs varied the most on TMHs 3 and 4,
whereas TMHs 1–2 and 5–10 were predicted by all methods
used, with slight extension differences (Fig. S1). Similar results
were obtained for other well-characterized UDP-GlcNAc
transporters from different species, including Homo sapiens
and Caenorhabditis elegans as well as for different members of
subfamily A, e.g. mouse Slc35a1, the only NST for which the
topology has been experimentally determined (32). Based on
this information, a 10-transmembrane helical model was pro-
posed as an initial working hypothesis for mSlc35a3 (Fig. 2).
Given the even number of TMHs and the positive inside rule
(48), we conclude that both the N and C termini would be ori-
ented to the cytoplasmic side. A general analysis of the amino
acid distribution in the model showed an accumulation of
charged and polar residues in luminal and cytoplasmic loops,
whereas within the transmembrane helices hydrophobic resi-
dues prevailed. A detailed assessment of the transmembrane
helices in the model revealed that five TMHs (1, 3, 4, 6, and 9)
were enriched in amino acids with polar characteristics,
whereas only three charged residues were identified, namely
Glu-47 and Lys-50 located in TMH2 and Lys-120 in TMH4
(Table 1).
Cys-scanning mutagenesis of transmembrane helix 2
As shown in Fig. 2, the mSlc35a3 amino acid sequence con-
tains three cysteine residues: Cys-54 in TMH2, Cys-64 in the
loop between TMH2 and TMH3, and Cys-184 in TMH6. To
generate a collection of cysteine-unique mutants, we first pro-
duced a cysteine-less variant (CL). Therefore, mSlc35a3 variant
containing substitutions corresponding to C54S/C64S/C184S
was generated and fused to GFP. The expression level of CL-
GFP in Kl3 cells was similar to that of WT–GFP (Fig. S2). After
incubation with GSII–FITC, cells bound close to 80% of the
lectin compared with cells expressing the WT protein (Fig. 3).
As assessed by phenotypic complementation of Kl3 cells, all
cysteine replacements were well-tolerated by the protein, indi-
cating that they are not essential for transport activity and con-
cluding that the CL mutant is functionally active in vivo.
Based on the bioinformatic results obtained for the mSlc35a3
sequence (Fig. 2 and Table 1), further experimental analysis
focused on the putative TMH2. Notably, TMH2, which was
predicted by all membrane topology programs used in this
study, is highly hydrophobic and contains two charged amino
acids embedded in the membrane. Charged and polar residues
in transmembrane domains of transport proteins are usually
involved in the binding of hydrophilic substrates, domain inter-
actions, or conformational changes as part of the transport
mechanism (49). Consequently, the corresponding codon of
each amino acid between leucine 38 to lysine 60 was substituted
by a cysteine codon using CL as a backbone, and a collection of
Figure 1. Expression of mSLC35A3 and phenotypic complementation of Kl3 cells. Kl8 cells were grown in YPD media, and Kl3 cells transformed with
plasmid pE4 (Mock), pE4-mSLC35A3 (WT), pE4-mSLC35A3–GFP (WT–GFP), or pE4-V180F-GFP (V180F-GFP) were grown in Ura media to an OD  2.0. A, GFP
fluorescence of the cell suspension was measured before (white bars) and after incubation at 90 °C for 1 min (light gray bars). The heated cells were incubated
with GSII–FITC lectin, and fluorescence associated with cell suspensions was measured (dark gray bars). Fluorescence measurements were normalized to
OD600 of the suspension and expressed as fluorescence arbitrary units (a.u.)/OD600. B, fluorescence of GSII–FITC bound to Kl3 cells expressing mSLC35A3
and variants. Background fluorescence of mock cells was subtracted, and values are expressed as a percentage of WT–GFP. Error bars represent the mean
and S.E. of three independent replicates. C, confocal microscopy fluorescence of Kl3 cells transformed with pE4 (Mock) or pE4-mSLC35A3GFP (WT-GFP)
plasmids. Scale bar, 4 m.
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23 cysteine-unique mutants fused to GFP was generated. As
shown in Fig. S2, all Kl3 transformants exhibited GFP fluores-
cence higher than cells transformed with the empty vector,
which decreased to mock background levels after heat treat-
ment. Incubation with GSII–FITC showed that most of the
cells expressing cysteine-unique mutants bound the lectin, with
fluorescence intensity values higher than 40% of the WT, con-
sistent with a restoration of the UDP-GlcNAc import into the
lumen of the Golgi apparatus (Fig. 3). The only exceptions were
mutants A42C, V44C, E47C, and K50C, which revealed a spe-
cific binding of GSII–FITC lower than 20% that of WT cells,
indicative of a severe impairment of transport activity.
Phenotypic complementation of Kl3 cells requires the syn-
thesis and incorporation of an active form of mSlc35a3 in mem-
branes of the secretory pathway (ER/Golgi apparatus). To
exclude incorrect membrane insertion or organelle localization
as a cause for the inability of these mutants to transport
UDP-GlcNAc, two approaches were undertaken. First, local-
ization of the C-terminally GFP-tagged mutants was evaluated
by confocal microscopy. Kl3 cells transformed with a plasmid
carrying different mutants and CL were grown to an OD600  2,
and the cellular localization of the GFP fluorescence signal was
analyzed. Similar to CL-GFP– expressing cells, perinuclear fluo-
rescence was observed for all mutants tested, a pattern consis-
tent with expression in the secretory pathway (Fig. 4A). Second,
membranes were isolated by ultracentrifugation, and proteins
abundant in these membrane fractions were separated by SDS-
PAGE and analyzed by in-gel fluorescence. As shown in Fig. 4B,
a predominant band for all mutants with mobility close to the
60-kDa marker was observed. This is consistent with the calcu-
lated molecular mass of 55 kDa corresponding to the fusion
protein mSlc35a3–GFP (Fig. 4). In agreement with the micros-
copy data, but not with whole-cell fluorescence results (Fig. S2),
the intensity of the main band of mutant 44 was slightly
lower compared with the others. Taken together, these
Figure 3. Analysis of cysteine-unique mutants by phenotypic comple-
mentation of Kl3 cells. Cells were grown in Ura media, heated, and
incubated with GSII–FITC 1 h at room temperature. The fluorescence of
GSII–FITC bound to Kl3 cells was measured and expressed as percentage
of the WT–GFP value. Error bars represent the mean and S.E. of three inde-
pendent replicates.
Table 1
Polar and charged amino acid residues located within the predicted
transmembrane helices of mSlc35a3. Charged residues are high-
lighted in bold
Transmembrane
helices Residue and no.
1 Ser-9, Gln-16, Thr-17, Thr-18, Ser-19, Thr-23
2 Glu-47, Lys-50
3 Ser-91, Tyr-94, Thr-95, Gln-97, Asn-98, Asn-99, Tyr-102
4 Gln-118, Lys-120, Thr-123, Thr-124, Ser-128
5 Ser-143
6 Thr-182, Ser-186, Ser-187
7 Ser-217
8 Thr-245, Gln-252
9 Thr-275, Ser-276, Ser-278, Ser-282, Thr-283, Ser-286,
Tyr-287
10 Thr-310
Figure 2. Ten transmembrane helices model of mSlc35a3. Amino acids with distinctive physicochemical properties are labeled as follows: green (nonpolar:
Gly, Ala, Val, Cys, Pro, Leu, Ile, Met, Trp, and Phe), orange (polar: Ser, Thr, Tyr, Asn, and Gln), blue (positively charged: Lys, Arg, and His), and red (negatively
charged: Asp and Glu). The three cysteines 54, 64, and 184 are highlighted in yellow.
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results strongly suggest that all variants were well-integrated
into the membranes of the secretory pathway, but in an inac-
tive form.
Analysis of involvement of Glu-47 and Lys-50 residues in
mSLC35A3-mediated transport through conservative
substitution analysis
To study the importance of residues Ala-42, Val-44, Glu-47,
and Lys-50 for the function of mSlc35a3, conservative
replacements were made using the WT sequence as backbone.
Kl3 cells transformed with the mutant alleles A42V, A42G,
V44A, V44I, or V44L fused to GFP showed fluorescence levels
similar to those observed for well-expressed proteins (white
bars, Fig. S3) and values of GSII–FITC binding between 50 and
140% compared with Kl3 cells expressing the WT transporter
(Fig. 5). The reduced binding of GSII–FITC in Kl3 cells express-
ing A42G (50%), but not in A42V (90%), suggests the impor-
tance of a lateral group, absent in the small and hydrophilic
amino acid glycine. In contrast, cells expressing all Val-44
mutants exhibited an increased abundance of glycoconjugates,
suggesting that the changes of V44A, V44I, or V44L improve
the function of mSlc35a3 and increase the concentration of
luminal UDP-GlcNAc. These results indicate that conservative
substitutions of Ala-42 or Val-44 are well-tolerated as revealed
by the in vivo transport activity. However, our data further sug-
gest that cysteine replacements in these positions are incom-
patible with the function of mSlc35a3.
To assess the role of glutamic acid 47 for mSLC35A3 activity,
mutations to alanine (E47A), aspartic acid (E47D), or glutamine
(E47Q) were generated, and Kl3 cells were transformed with
the corresponding variants. As shown in Fig. S3, expression of
the mutant E47A was not detectable, whereas E47D and E47Q
were expressed at similar levels compared with the WT protein.
The in vivo activity was assessed by incubation of Kl3 transfor-
mants with GSII–FITC lectin. Cells expressing the E47D
mutant bound 47% of the lectin compared with control cells
transformed with the WT protein. By contrast, the substitution
E47Q completely abolished the biosynthesis of GlcNAc glyco-
conjugates and showed no binding. The significance of lysine
50 was examined by substituting Lys-50 with alanine (K50A),
histidine (K50H), or arginine (K50R). Kl3 cells were trans-
formed with the corresponding mutant variants, and expres-
sion was monitored by whole-cell GFP fluorescence. As is
shown in Fig. S3, no expression was detectable for K50H,
whereas the K50A and K50R variants were expressed at sim-
ilar levels to those of the WT protein. Upon incubation of Kl3
cells expressing the K50R mutant with GSII–FITC, low lev-
els of GlcNAc were detected, suggesting severely impaired
transport activity.
To explore a possible interaction between both charged
amino acids, double mutants were generated and expressed in
Kl3 cells (Fig. S3). To elucidate whether a charge misbalance in
the individual mutations (E47C or K50C) caused the impair-
ment in transport activity, both charges were neutralized
(E47A/K50A). To analyze whether their specific positions in
TMH2 are of particular relevance, both residues were inter-
changed (E47K/K50E). Finally, a mutant containing substitu-
Figure 4. Localization and membrane insertion of inactive mutants. A,
cells transformed with the empty vector pE4 (Mock), pE4-CL-GFP, and pE4
containing the mutated versions A42C, V44C, E47C, and K50C were grown in
Ura media to an OD  2, and GFP fluorescence was visualized by confocal
microscopy. Scale bar, 4 m. B, proteins associated with membranes were
obtained by ultracentrifugation and separated by SDS-PAGE, and in-gel fluo-
rescence was determined. The lane numbers on the gel correspond to the
follows: lane 1, mock; lane 2, CL; lane 3, A42C; lane 4, V44C; lane 5, E47C; lane 6,
K50C; and lane 7, mass marker.
Figure 5. Analysis of single and double mutants of mSlc35a3. Kl3 cells
were transformed with the empty vector pE4, pE4-WT–GFP, or pE4 carrying
single and double mutants of mSlc35a3 fused to GFP. Cells were grown in
Ura media, isolated, heated for 1 min at 90 °C, and incubated with GSII-FICT
for 1 h at room temperature. Fluorescence of the cell suspensions was mea-
sured and expressed as a percentage of WT–GFP. Error bars represent the
mean and S.E. of three independent replicates.
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tions of the residues that lead to simultaneous changes in length
but conservation of the original charge (E47D/K50R) was gen-
erated. As shown in Fig. 5, neutralization of the charge or inter-
change of the position disrupts the production of GlcNAc gly-
coconjugates on the surface of Kl3 cells transformed with the
corresponding plasmids. Kl3 cells expressing the E47D/K50R
mutant bound less than 20% of the lectin compared with cells
expressing the WT protein, suggesting an additive effect of the
corresponding individual mutations.
Glu-47 and Lys-50 are critical for UDP-GlcNAc/UMP exchange
activity of mSlc35a3
Phenotypic complementation of Kl3 cells was used as an
efficient way to screen and identify relevant residues. However,
limited information could be obtained about the specific
properties of the mSlc35a3 variants. To study the UDP-
GlcNAc transport properties of mSLC35A3 and the effect of the
mutations E47D, E47Q, K50R, and K50H in detail, the WT
protein as well as the variants were heterologously expressed in
Saccharomyces cerevisiae. Membrane proteins were reconsti-
tuted into liposomes, and the corresponding proteoliposome
preparations, preloaded with UMP, were incubated with
UDP-GlcNAc, and nucleotide sugar uptake was evaluated by
MS. UDP-GlcNAc uptake was saturable in a time- and con-
centration-dependent manner (Fig. 6, A and B). Determina-
tions of the kinetic parameters of UDP-GlcNAc transport
activity mediated by the WT mSLC35A3 revealed a Km of 22
M and Vmax of 894 nM s1 (Table 2). In contrast, proteoli-
posomes containing the corresponding mutant variants
E47D, E47Q, K50R, or K50H showed UDP-GlcNAc accumu-
lation over time with variable levels between 1 and 10% com-
pared with the WT (Fig. 6B). Velocities were dramatically
affected in Glu-47 and Lys-50 substitutions with values close
to 10 and 1% of WT mSlc35a3. The apparent affinities of the
variants for UDP-GlcNAc showed a decrease for all mutants
except for E47D (Table 2).
EXXK motif is specific to subfamily A members and conserved
among species
A multiple alignment generated from the putative TMH2
amino acid sequences of mSlc35a3 and other members of the
mouse SLC35 family revealed that the EXXK motif containing
Glu-47 and Lys-50 is present only in subfamily A (Fig. 7), indi-
cating uniqueness of the motif and possibly providing distinct
structural/functional properties. In addition, the motif is found
in characterized NSTs across a variety of species ranging from
unicellular organisms like Entamoeba histolytica (50) and yeast
(51) to worms (4), plants (52), and mammals (29, 45). This sug-
gests an early occurrence of this subfamily in eukaryotes and an
adaptation to transport diverse substrates during evolution.
Interactions between TMH2/TMH7 and TMH2/TMH8 were
predicted by coevolution studies of amino acid residues
Evolutionary constraints on the function and structure of
proteins are reflected in conserved interactions between pairs
or groups of amino acids (53). To evaluate possible interactions
involving residues of TMH2 in the context of the whole protein,
the mSlc35a3 sequence was analyzed using the algorithm
EVfold_membrane. This algorithm extracts coevolution pat-
terns from multiple sequence alignments using an entropy
maximization approach (54). The scoring of evolutionarily con-
strained pairs, many reflecting interactions between residues
close in space, suggests that residues from TMH2 interact with
residues of TMH7 and TMH8. As shown in the contact map
(Fig. S4) from 330 evolutionary couplings, specifically, the five
pairs Val-44/Leu-221, Ile-51/Phe-214, Ile-51/Ser-217, Phe-48/
Ser-217, and Ile-55/Ile-210 are predicted to interact between
TMH2 and TMH7, and the two pairs Ala-53/Ala-253 and Leu-
Figure 6. In vitro activities of mSlc35a3 and variants. A, proteoliposomes containing WT or mutants, preloaded with 30 mM UMP, were incubated with
UDP-GlcNAc at a concentration of 50 M for the indicated time points at 37 °C. UDP-GlcNAc uptakes are expressed in nanomoles normalized to the total protein
content in proteoliposomes (four independent replicates). B, proteoliposomes containing WT and mutants, preloaded with 30 mM UMP, were incubated with
UDP-GlcNAc at varying concentrations (0.5–200 M) for 30 s at 37 °C. Activity values were normalized to the GFP fluorescence in proteoliposome preparations.
For each mSLC35A3 variant, 10 data points (four independent replicates) were acquired, and a hyperbolic function was fitted by nonlinear regression using the
Prism 7 application. Best fit kinetic parameters are shown in Table 2 and are represented as the mean  S.E.
Table 2
Kinetic parameters of UDP-GlcNAc transport mediated by mSlc35a3
and selected mutants
WT E47D E47Q K50R K50H
Km (M) 22  3 7  1 108  46 63  17 307  152
Vmax (nM s1) 894  29 114  4 72  15 7  1 3  1
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49/Val-248 are predicted to interact between TMH2 and
TMH8. Our results revealed no coevolution pairs between
TMH7 and TMH8 suggesting a localization on opposite sides of
TMH2. For the highly conserved residues Glu-47 and Lys-50,
no interaction with residues of other TMHs were predicted.
Finally, the 3D structure of the protein was computed using
EVfold_membrane, based only on the predicted residue con-
tacts and restrictions imposed by topology (54). The resulting
model, shown in Fig. S5, contains 10 TMHs with an arrange-
ment resembling the structure of members of the drug/metab-
olite transporter (DMT) superfamily that have been crystallized
so far (44, 55, 56).
Homology model of mSlc35a3
A homology model of mSlc35a3 was generated using the
Phyre2 Protein Fold Recognition Server (57). The model was
built on the basis of the structure of Vrg4 (PDB code 5OGE),
and the quality of the model was tested using the structure-
validated web server Molprobity (58). A comparison of the ho-
mology model (Fig. 8) with the model obtained using coevolu-
tionary information (Fig. S5) shows that they are highly similar.
The resulting models contain 10 TMHs folded in two with a
central cavity limited by TMH2– 4 and TMH6 –9, whereas
TMH5 and TMH10 outside this core structure appear as a zip-
per. Residues Glu-47 and Lys-50 seem to be oriented to the
same side of TMH2 facing the central cavity of the protein
(Fig. 8B).
Discussion
In this work, a combination of bioinformatic and experimen-
tal approaches identified two charged residues, Glu-47 and Lys-
50, as potentially important for mouse Slc35a3 function. Con-
servative substitutions of these amino acids resulted in a severe
impairment of mSlc35a3 function with a dramatic reduction in
UDP-GlcNAc/UMP exchange, thereby highlighting the critical
role of Glu-47 and Lys-50. Shortening the length of the side
chain in E47D and elimination of the charge in E47Q affected
the UDP-GlcNAc transport capacity of mSlc35a3 (Figs. 5
and 6), indicating the requirement of the negative charge and
side-chain length, likely involved in interactions during the
UDP-GlcNAc/UMP exchange. Even more dramatic effects
were caused by substitutions of Lys-50, which almost com-
pletely inactivated UDP-GlcNAc transport activity, both in vivo
and in vitro (Figs. 5 and 6).
An analysis of the topology of the protein indicates that res-
idues that maintain close spatial proximity are embedded in the
highly hydrophobic center of TMH2. Charge balance, relative
position, or intrahelix interactions of Glu-47 and Lys-50 were
explored by generating the double mutants E47A/K50A, E47K/
K50E, and E47D/K50R. For all double mutants, the phenotypic
complementation assay indicated a very low flux of UDP-GlcNAc
into the Golgi lumen suggesting that the relative position of the
charges in the TMH2 are critical for mSlc35a3 function.
Sequence comparisons of members of the mouse SLC35
family showed that the motif EXXK present in TMH2 is specific
to members of SLC35 subfamily A (Fig. 7). The identified sub-
strates for Slc35a1, -a2, and -a3 (CMP-SA, UDP-Gal, and
UDP-GlcNAc, respectively) are highly diverse in terms of their
nucleotide and sugar residues (29 –31). Therefore, it is difficult
to directly associate these charged amino acids of the consensus
motif with an initial ligand recognition on the cytosolic side of
the transporter. However, the corresponding nucleotides are
pyrimidines and have a common structure that could be recog-
nized. One hypothesis could be that the negatively charged
phosphate group of the nucleotide sugar or the nucleoside
monophosphate could interact with these charged residues
during ligand recognition. The alteration of the kinetic param-
eters in the mutants (Table 2) is compatible with the coordina-
tion of one or both ligands.
Moreover, the participation of the two charged residues of
the consensus motif could be related to a secondary event that is
common to all members of subfamily A, e.g. the helix– helix
interactions or conformational changes as part of an alternating
access mechanism. The coevolution analysis of mSlc35a3 pre-
dicted an interaction between TMH2 and TMH7 via five con-
Figure 7. Multiple sequence alignment of mSLC35 members. The sequences of the predicted members of family SLC35 from mice were aligned using
Clustal Omega. Residues corresponding to TMH2 of mSLC35A3 are underlined. The conserved residues of the motif EXXK are colored in red (Glu) and blue (Lys).
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tact points (Fig. S4). Particularly, three of those involved resi-
dues Phe-48 (with Ser-217 residue) and Ile-51 (with Phe-214
and Ser-217 residues) that are located right next to Glu-47 and
Lys-50 in the sequence of TMH2. Studies on chimeric proteins
Slc35a1 and -a2 showed that a swap of the amino acid
sequences corresponding to TMH2, TMH3, and TMH7 from
Slc35a1 to Slc35a2 conferred CMP-SA specificity in addition to its
originally identified substrate UDP-Gal. Moreover, the introduc-
tion of Tyr-214 and Ser-216 residues from Slc35a1 at the same
position into Slc35a2–TMH7 revealed that they are critically
important for the recognition of CMP-SA. Altogether, based on
these results it can be assumed that certain residues of TMH7
could be important for the recognition of the substrate, whereas
others may be involved in interactions with residues of TMH2 as
part of the coupling mechanism.
High-resolution crystal structures have been obtained for
three other members of the DMT superfamily, to which the
NSTs belong. The structural analyses of SnYddG, a bacterial
aromatic amino acid exporter (55), GsGPT, a eukaryotic or
3-phosphoglycerate (3-PGA)/Pi translocator (56), and Vrg4,
the GDP-mannose (GDP-Man) transporter from yeast (44),
revealed 10 TMHs folded into the N- and a C-terminal halves
(55). The structural results for GsGPT, bound to Pi or 3-PGA,
showed that the phosphate moieties (P-O2, O3, and O4) of Pi or
3-PGA are recognized by ionic bonds with Lys-204 (TMH4)
and Lys-362/Arg-363 (TMH9) and a hydrogen bond with Tyr-
339 (TMH8). The glycerate group of 3-PGA specifically inter-
acts via an ionic bond with His-185 (TMH3), a hydrogen bond
with Tyr-339 (TMH8), and hydrophobic contacts with Thr-
188, Phe-192 (TMH3), and Phe-263 (TMH6). Mutational anal-
yses and molecular dynamics simulations confirmed the signif-
icance of these residues. They revealed that Glu-207 (TMH4),
the only conserved acidic residue in the positively charged
binding pockets, is critical as a molecular switch, interacting
with Lys-204 (TMH4) or Arg-363 (TMH9) (59). Sequence com-
parisons of subfamily members with distinct sugar-phosphate
specificities suggest conservation of these residues that interact
with the phosphate moieties and variability within the residues
that interact with the sugar, hence determining the specificity.
The structure of the yeast GDP-Man transporter Vrg4 was
resolved in the apoprotein and GDP-Man– bound forms (44).
The results showed that the nucleotide and sugar are accom-
modated within separate binding pockets. The nucleotide
pocket is composed of side chains of the residues Asn-220 and
Asn-221 located within TMH7 and Ser-266 (TMH8) that inter-
act with guanine, and Tyr-28 (TMH1), Ser-269 (TMH8) and
Tyr-281 (TMH9) that interact with the ribose group. Met-35
(TMH1) interacts with the first phosphate and Lys-289
(TMH9) interacts with the -phosphate and the glycosidic-
bond oxygen. Tyr-114, located within TMH4, is involved in
sugar binding via the C2 hydroxyl group on the mannose ring.
Based on the structural and mutational analyses, the authors
proposed an alternating-access mechanism (44). The interac-
tion of conserved residues from the two inverted repeats
TMH1–5 and TMH6 –10, Ser-32 (TMH1), Lys-289 (TMH9),
Asn-191 (TMH6), and Lys-118 (TMH4), are formed and bro-
ken during the transport cycle.
Fig. 8 shows the homology model for mSlc35a3 based on the
crystallographic structure of Vrg4. Remarkably, this model is
very similar to the coevolution model (Fig. S5). Both models
Figure 8. Homology-based model of mSlc35a3. The homology model was generated as was described under “Experimental procedures.” A, ribbon repre-
sentation of the structure, viewed from the plane of the membrane (left) and luminal side (right). B, ribbon representation of TMH2, TMH7, and TMH8.
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show 10 TMHs distributed in two halves, TMH1– 4 and
TMH6 –9, defining a central cavity. However, there are signif-
icant differences in the distribution of charged residues embed-
ded in the TMHs between Vrg4 and the mSlc35a3 model. The
exception is a common Lys on TMH4 (Lys-118 in Vrg4 and
Lys-120 in mSlc35a3). A positively charged residue corre-
sponding to the relevant Lys-289 is not present in TMH9 of
mSlc35a3 and, on the contrary, no charged residues are present
on the TMH2 of Vrg4.
From these data, some common features of the structures of
the DMT superfamily (60) begin to emerge. On one side, struc-
tural models suggest similar folding for all 10 TMH members
despite the low sequence identities between these proteins
(about 10%), and an evolutionary adaptation to transport mol-
ecules with different chemical characteristics that seem to be
based on common folding and mechanism. On the other side,
charged residues are involved in the interaction with ligands,
particularly with the phosphate groups, and in helix– helix
interactions during conformational transitions of the alternat-
ing access mechanism. Our results show that mSlc35a3 would
have only three charged residues within its transmembrane
domains, Glu-47, Lys-50, and Lys-120 (Table 1). The last resi-
due is located in TMH4 and corresponds to Lys-118 from Vrg4,
which is proposed to be part of the interaction with the C-
half of the inverted repeats during the alternating access
mechanism.
The crystal structure of Vrg4 seems to adopt a dimer
arrangement, involving both the TMH5 and the TMH10 inter-
face. The localization of the TMH2 on the opposite side of the
protein (based on the homology model), seems to rule out an
involvement of residues Glu-47 or Lys-50 in the dimerization of
mSlc35a3. We speculate that Glu-47 and Lys-50 residues in the
context of the interacting helices TMH2–TMH7 and TMH8
are involved in protein–ligand interactions and/or conforma-
tional transitions between the N- and the C-terminal halves of
the protein, which should be an obligatory step for the
exchange UDP-GlcNAc/UMP. However, that leaves open the
question of how charged residues located in different TMHs




Common chemicals used in this work were of analytical
grade and were obtained from Sigma. Yeast extract and peptone
were obtained from Britannia (Argentina).
Bioinformatic analysis
The primary amino acid sequences of the SLC35 family
proteins were analyzed using the following topology predictors:
TOPCONS (61), MEMSAT-SVM (62), HMMTOP (63), and
TMHMM (64). Sequence alignments were generated using
Clustal Omega (65).
Molecular biology
Unless otherwise stated, standard molecular biology proto-
cols were applied as described in Ref. 66. The Mus musculus
slc35a3 gene (mSLC35A3) was PCR-amplified from cDNA
(clone ID 5150304, Open Biosystem) using DNA polymerase
(Bioline, USA) and primers XhoI–Mmf 5-GCGGCGCTCGA-
GATGTCTGCCAACCTAAAATAT-3 and Mm-EcoRI 5-
CGCCGCGAATTCCTATGCTTTAGTGGGATTTCC-3. The
resulting PCR product was digested with XhoI and EcoRI and
subsequently ligated into the pE4 vector (47) to obtain the plas-
mid pE4-mslc35a3 for expression in the K. lactis mutant 3
(Kl3). To generate a GFP fusion (mslc35a3-GFP) in pE4, the
mslc35a3 sequence was introduced into the vector p426Gal-
GFP (67) by homologous recombination and subsequently sub-
cloned into the pE4 vector.
In the first step, the PCR product was obtained using the
following primers (EcoRI): mouse RECf (5-TCGACGG-
ATTCTAGAACTAGTGGATCCCCCGAATTCATGTCTG-
CCAACCTAAAATAT-3) and mouse RECr (5-AAA-
TTGACCTTGAAAATATAAATTTTCCCCTGCTTTAG-
TGGGATTTCCTGC-3). The plasmid p426Gal-GFP was
digested with SmaI and transformed into S. cerevisiae
FGY217 (kindly provided by Prof. Ljungdahl). The plasmid
p426Galmslc35a3–GFP, purified from S. cerevisiae, was digested
with EcoRI to release the insert EcoRI–mslc35a3–GFP–EcoRI
and subsequently ligated into the vector pE4. The correct ori-
entation was confirmed by colony PCR using appropriate prim-
ers. Plasmid p426Gal–GFP was obtained essentially as
described previously (67). In brief, the GFP sequence was PCR-
amplified from pUG35 plasmid (kindly provided by Dr.
Johannes Hegemann), using the following primers: TEVGFPfor
(5-GAAAATTTATATTTTCAAGGTCAATTTTCTAAAG-
GTGAAGAATTATTCAC-3) and GFPhisrev (5-TTAA-
TGATGATGATGATGGTGGTGGTGTTTGTACAATTCA-
TCCATACC-3). The corresponding PCR fragment was used




GATGATGATGGTGGTGG-3) to add recombination
sequences. Finally, the PCR product was introduced into the
pRS426GAL1 plasmid (kindly provided by Dr. James
Konopka) digested with SmaI by homologous recombination
into the FGY217 yeast strain.
To obtain the CL mutant, the following protocol was used.
First, two fragments were obtained by PCR. Fragment A with
primers (EcoRI) mouseRECf/C54S/C64Sr and fragment B with
primers C184Sf/mouseRECr (Table S2) using mslc35a3 cDNA
as template were used. After purification, both fragments were
used in PCR to obtain the full-length fragment with the corre-
sponding serine codons replacing the cysteine codons. The cys-
teine-unique mutants were generated using the primers listed
in Table S2 (L38C to K60C) and employing the megaprimer
method (68) in two rounds of PCR. In the first round, a frag-
ment (megaprimer) containing the mutation was obtained in
combination with primer (EcoRI)mouseRECf. In the second
round, the megaprimer was used in combination with the
primer mouseRECr to obtain the full-length version. In both
rounds, the CL sequence obtained was used as a template.
Finally, single- and double-point mutations of WT-mslc35a3
were obtained essentially as described for a unique cysteine
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mutant using the WT cDNA as template and the corresponding
primers (E47Dr, E47Qr, E47Ar, E47Cr, K50Rr, E47K/K50Er,
E47D/K50Rr, V44Ar, V44Lr, and V44Ir). The identity of the
cloned fragments was confirmed by DNA sequencing.
Yeast strain, transformation, and growth media
For transformation of the K. lactis mutant 3 (Kl3, Mata, uraA,
mnn2-2, arg2 K, pKD1) a lithium acetate/PEG method was
utilized (69). Cells were grown in complete YPD media (0.75%
yeast extract, 1.13% peptone, 2.2% dextrose), and transformants
were selected by their ability to grow at 28 °C in the absence of
uracil (Ura media) on plates containing 0.67% yeast nitrogen
base with ammonium sulfate without amino acids (YNB), 0.08%
complete supplemented medium minus Ura (Ura), 2.0% dex-
trose, and 2.0% agar. WT K. lactis cells (Kl8), used as a positive
control for the UDP-GlcNAc transporter complementation
assays, were grown at 28 °C in YPD media.
Cell surface labeling of K. lactis with GSII–FITC
To assay the activity of the mouse Slc35a3 variants, Kl3 cells
transformed with the corresponding pE4 vector (31) were
grown overnight in 5 ml of synthetic uracil dropout media to an
OD600  1–2 as described earlier (31). Cells were collected by
centrifugation and washed with Solution I (150 mM NaCl, 0.5
mM CaCl2). Cell density was estimated at 600 nm (OD600), and
an aliquot, corresponding to 2 units of OD600, was isolated by
centrifugation and subsequently resuspended in 200 l of solu-
tion I. GFP fluorescence (excitation, 485 nm/emission, 514 nm)
was measured before and after incubation at 90 °C for 1 min to
estimate the expression of the corresponding mSLC35A3–GFP
variants (WT or mutants). After the 90 °C incubation step, the
cells were harvested by centrifugation; the supernatant was dis-
carded; and the pellet was incubated in the presence of 25 l of
GSII–FITC (EY Laboratories) labeling solution (3 parts of
lectin  1 part 150 mM NaCl, 4 mM CaCl2) for 1 h at 25 °C. After
this step, the cells were pelleted, washed with 1.5 ml of solution
I, and resuspended in 200 l of solution I before the GFP fluo-
rescence was determined. Fluorescence measurements were
normalized to the OD600.
Confocal microscopy of yeast expressing mSlc35a3-GFP
Kl3 cells transformed with pE4 and pE4-MmSLC35A3–GFP
(WT or mutants) were mounted on YSB buffer and imaged
using an Olympus Fluoview FV1000 spectral laser-scanning
confocal microscope with a 60 oil immersion lens using
473 nm excitation. GFP fluorescence emission was collected
between 500 and 550 nm.
Analysis of the membrane integration of the mSlc35a3–GFP
fusions using in-gel fluorescence analysis
Total membrane fractions were prepared using glass beads to
disrupt the cell pellets derived from 10-ml yeast cultures
(OD600  1–2) in YSB buffer (10% glycerol, 5 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 50 mM Tris-HCl, pH 7.6). The
suspensions were centrifuged at 2,000  g followed by centrif-
ugation of the supernatants at 100,000  g for 1 h. Resulting
membrane pellets were resuspended in YSB buffer prior to
protein separation by electrophoresis on 12% SDS-poly-
acrylamide gels (70). Gels were scanned using a Storm 840
molecular imager (Amersham Biosciences) to determine
GFP fluorescence.
In vitro transport assay
UDP-N-acetyl--D-glucosamine (UDP-GlcNAc) was obtained
from Sigma. The yeast strain INVScI (Thermo Fisher Scientific)
was transformed using the S.c. EasyCompTM transformation kit
(Thermo Fisher Scientific). Yeast growth, cell disruption, mem-
brane isolation, membrane protein reconstitution into lipo-
somes, transport activity assays, and MS were performed as
described previously in detail (12). Kinetic parameters were cal-
culated by nonlinear regression using the Prism 7 application
(GraphPad Software, La Jolla, CA).
Coevolution analysis
The coevolution analysis of residues pairs of MmSlc35a3 was
performed using the EV coupling web interface (http://
evfold.org/evfold-web/evfold.do)8 (54).
Homology modeling
The homology model of mSlc35a3 was generated using the
Phyre2 Protein Fold Recognition Server (http://www.sbg.
bio.ic.ac.uk/phyre2) (57). The model was built on the basis of
the structure of Vrg4 (PDB code 5OGE). Model quality was
tested using the structure-validate web server Molprobity
(http//molprobity.biochem.duke edu)8 (58).
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Addendum—During the review process of this manuscript, new
information about the structure of a plant CMP-sialic acid trans-
porter, CSTZM, was made available (Nji, E., Gulati, A., Qureshi,
A. A., Coincon, M., and Drew, D. (2019) Structural basis for the
delivery of activated sialic acid into Golgi for sialylation. bioRxiv
CrossRef). This work has shown that residues Glu-42 and Lys-45 on
TMH2 are critical for the coordination of the ligand CMP. The coor-
dinates of the structures corresponding to CMP bound CSTZM
(PDB code 6I1R) and apo CSTZM (PDB code 6I1Z) have been depos-
ited in the Protein Data Bank.
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